The newly synthesized HDAC6 inhibitor, HGC, was discovered to rescue dopaminergic neuron loss in PD models by inducing acetylation of NDUFV1, thus demonstrating significant therapeutic potential for treating PD [55]. Here, NDUFV1 is linked to Parkinson disease.